Publications by authors named "Miguel Forte"

Claim this Profile
I
International Call for a 10-Year Moratorium on Heritable Human Genome Editing: A multi-stakeholder initiative to ensure safe and responsible use of genetic technologies May 2025.
David Barrett, Paula Cannon, Miguel Forte, Tim Hunt, Queenie Jang

Cytotherapy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges.
Abdulrahman Alsultan, Dominique Farge, Sven Kili, Miguel Forte, Daniel J Weiss

Cytotherapy· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.
Laertis Ikonomou, Natividad Cuende, Miguel Forte, Bambi J Grilley, Aaron D Levine

Cytotherapy· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products.
Natividad Cuende, Rachele Ciccocioppo, Miguel Forte, Jacques Galipeau, Laertis Ikonomou

Cytotherapy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
Arnaud Foussat, Sylvie Gregoire, Nathalie Clerget-Chossat, Celine Terrada, Hélène Asnagli, Miguel Forte

J Ocul Pharmacol Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Welcome to ISCT 2017 London.
Miguel Forte, Mark Lowdell, Katy Rezvani

Cytotherapy· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The path to successful commercialization of cell and gene therapies: empowering patient advocates.
Gerhard Bauer, Mohamed Abou-El-Enein, Alastair Kent, Brian Poole, Miguel Forte

Cytotherapy· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Science, ethics and communication remain essential for the success of cell-based therapies.
Massimo Dominici, Karen M Nichols, Aaron D Levine, John Ej Rasko, Miguel Forte

Brain Circ· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 5: Unproven cell therapies and the commercialization of cell-based products.
Robert J Deans, Kurt C Gunter, Massimo Dominici, Miguel Forte

Cytotherapy· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.
Massimo Dominici, Karen Nichols, Alok Srivastava, Daniel J Weiss, Paul Eldridge, Miguel Forte

Cytotherapy· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns.
Natividad Cuende, Christelle Boniface, Christopher Bravery, Miguel Forte, Rosaria Giordano

Cytotherapy· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
Pierre Desreumaux, Arnaud Foussat, Matthieu Allez, Laurent Beaugerie, Xavier Hébuterne, Miguel Forte

Gastroenterology· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis